Skip to main content

Rafael Simó Canonge

Institutions of which they are part

Head of group
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Rafael Simó Canonge

Institutions of which they are part

Head of group
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Projects

Identificación de los mecanismos moleculares que regulan la expresión de la Sex hormone-binding globulin (SHBG) en el desarrollo y progresión de la diabetes de tipo 2 y de la distrución de la grasa corporal

IP: Rafael Simó Canonge
Collaborators: David Martinez Selva, Miriam Izquierdo Sans
Funding agency: Instituto de Salud Carlos III
Funding:
Reference: CP07/00180
Duration: -

Mediadors patogènics de l'edema macular diabètic: Estudi comparatiu amb la retinopatia diabética proliferativa i exploració de nous candidats mitjançant anàlisi proteòmica a l'humor vitri

IP: Rafael Simó Canonge
Collaborators: -
Funding agency: Fundació Institut de Recerca HUVH
Funding: 14507.28
Reference: PRED/IR-HUVH/11/2007
Duration: 01/01/2008 - 31/10/2011

RECAVA - Red Temática de Investigación en Enfermedades Cardiovasculares

IP: Rafael Simó Canonge
Collaborators: Cristina Hernández Pascual, David Martinez Selva, Monica Higuera Urbano, Patricia Bogdanov Baruj
Funding agency: Instituto de Salud Carlos III
Funding: 34740
Reference: RD06/0014/1014
Duration: 01/01/2008 - 31/12/2014

Hospital Universitari MAS

IP: Rafael Simó Canonge
Collaborators: -
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 11400
Reference: 2007 BE-1 10072
Duration: 10/09/2007 - 10/03/2008

Related news

The work represents a paradigm shift in the clinical approach to this chronic, multifactorial disease, based on the clinical context of each patient and not only on weight loss.

The results of a phase 3 clinical trial show that orforglipron reduces body weight by an average of 11% and improves cardiovascular risk factors.

Dr. Maria Llorián-Salvador, from the Diabetes and Metabolism Research Group at VHIR, is leading this project to identify new therapies for this inherited disease that causes progressive vision loss.

Related professionals

Tao Gonzalez Zaragoza

Tao Gonzalez Zaragoza

Zelador/a
General Services and Infrastructures Unit
Infrastructure Coordination
Manager
Read more
Cristina Avila Fumanal

Cristina Avila Fumanal

Growth and Development
Read more
Mireia  Beltran  Porres

Mireia Beltran Porres

Growth and Development
Read more
Anna Enrich  Font

Anna Enrich Font

Research technician
Clinical Research/Innovation in Pneumonia & Sepsis (CRIPS)
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.